Chronic hyperprolactinemia causes progressive changes in hypothalamic dopaminergic and noradrenergic neurons

Area of Science:

• Neuroendocrinology
• Neuropharmacology
• Endocrinology

Background:

• Chronic hyperprolactinemia (HYP) is associated with altered neurotransmitter systems.
• The MtTW15 tumor model provides a means to induce sustained HYP in rats.

Purpose of the Study:

• To investigate the impact of chronic HYP on catecholamine concentrations and turnover in specific brain regions of female rats.
• To determine if normalization of prolactin (PRL) levels reverses these neurochemical alterations.

Main Methods:

• Induction of HYP via MtTW15 tumor inoculation in female rats.
• Measurement of serum PRL levels, and catecholamine (dopamine and norepinephrine) concentrations and turnover rates in brain regions (MBH, POA-AH) and the pituitary (NIL).
• Assessment of neurochemical changes following tumor removal.

Main Results:

• Elevated PRL levels initially increased DA turnover in the MBH, followed by decreased DA concentrations and turnover with sustained HYP.
• POA-AH showed reduced DA concentrations and turnover, while NE turnover decreased in both MBH and POA-AH.
• Tumor removal normalized PRL but did not reverse MBH DA deficits or NE turnover reductions in MBH and POA-AH.

Conclusions:

• Severe chronic HYP induces progressive, long-lasting alterations in hypothalamic dopamine and norepinephrine neuronal systems.
• These neurochemical changes are not fully reversible upon normalization of serum PRL levels.
• Chronic HYP can result in persistent neurobiological consequences on catecholamine pathways.